SPAG9 and ovarian carcinoma: ,78,79,80,81,82,83 SPAG9 silencing in combination with paclitaxel treatment synergistically inhibited ovarian cancer cell viability, and SPAG9 depletion in ovarian cancer xenograft mouse models significantly reduced tumor growth.81